GPT and metabolic dysfunction-associated steatotic liver disease: In the ‘No fibrosis’ group and the ‘Fibrosis’ group, the mean (± SD) AST/ALT ratio were 0.89 ± 0.30 and 1.24 ± 0.81, respectively (p-value=0.029); the mean (± SD) APRI score was 0.38 ± 0.42 and 0.80 ± 1.36 (p-value=0.108); the mean (± SD) FIB-4 index was 1.16 ± 0.57 and 2.15 ± 1.85 (p-value=0.007); the BARD score mean (± SD) was 2.57 ± 1.06 and 2.93 ± 1.04, (p-value=0.103); the mean (± SD) NAFLD-fibrosis score was -1.54 ± 1.06 and -0.61 ± 1.81 (p-value=0.012).